{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:38:56Z","timestamp":1790933936666,"version":"4.1.0"},"reference-count":38,"publisher":"American Association for Cancer Research (AACR)","issue":"11","license":[{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020105","name":"VIVA Foundation for Children with Cancer","doi-asserted-by":"publisher","award":["VIVA-KKH Paediatric Brain and Solid Tumour Programme"],"award-info":[{"award-number":["VIVA-KKH Paediatric Brain and Solid Tumour Programme"]}],"id":[{"id":"10.13039\/100020105","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001543","name":"Children's Cancer Foundation","doi-asserted-by":"publisher","award":["Singapore Childhood Cancer Registry"],"award-info":[{"award-number":["Singapore Childhood Cancer Registry"]}],"id":[{"id":"10.13039\/100001543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","award":["Target Translation Consortium TDR-005-008"],"award-info":[{"award-number":["Target Translation Consortium TDR-005-008"]}],"id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"MOH | National Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>XIAP, the most potent mammalian inhibitor of apoptosis protein (IAP), critically restricts developmental culling of sympathetic neuronal progenitors, and is correspondingly overexpressed in most MYCN-amplified neuroblastoma tumors. Because apoptosis-related protein in the TGF\u03b2 signaling pathway (ARTS) is the only XIAP antagonist that directly binds and degrades XIAP, we evaluated the preclinical effectiveness and tolerability of XIAP antagonism as a novel targeting strategy for neuroblastoma. We found that antagonism of XIAP, but not other IAPs, triggered apoptotic death in neuroblastoma cells. XIAP silencing induced apoptosis while overexpression conferred protection from drug-induced apoptosis. From a screen of IAP inhibitors, first-in-class ARTS mimetic A4 was most effective against high-risk and high XIAP-expressing neuroblastoma cells, and least toxic toward normal liver- and bone marrow\u2013derived cells, compared with pan-IAP antagonists. On target engagement assays and nuclear magnetic resonance spectroscopy, A4 was observed to degrade rather than inhibit XIAP, catalyzing rapid degradation of XIAP through the ubiquitin-proteasome pathway. In MYCN-amplified neuroblastoma patient-derived xenografts, A4 significantly prolonged survival as a single agent, and demonstrated synergism with standard-of-care agents to reduce their effective required doses 3- to 6-fold. Engagement and degradation of XIAP by ARTS mimetics is a novel targeting strategy for neuroblastoma that may be especially effective against MYCN-amplified disease with intrinsically high XIAP expression. First-in-class ARTS mimetic A4 demonstrates preclinical efficacy and warrants further development and study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>XIAP degradation is sufficient to kill MYCN-amplified neuroblastoma which overexpresses and relies on XIAP as a brake against cell death, without affecting normal cells.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-23-0082","type":"journal-article","created":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T09:29:37Z","timestamp":1698139777000},"page":"2386-2399","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Targeted Degradation of XIAP is Sufficient and Specific to Induce Apoptosis in MYCN-overexpressing High-risk Neuroblastoma"],"prefix":"10.1158","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0507-1932","authenticated-orcid":true,"given":"Zhang'E","family":"Choo","sequence":"first","affiliation":[{"name":"1Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore."},{"name":"2NUS Centre for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9888-0488","authenticated-orcid":true,"given":"Xiaoying","family":"Koh","sequence":"additional","affiliation":[{"name":"3Experimental Drug Development Centre, A*STAR, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4688-7879","authenticated-orcid":true,"given":"Megan Rui En","family":"Wong","sequence":"additional","affiliation":[{"name":"4VIVA-KKH Paediatric Brain and Solid Tumour Programme, Children's Blood and Cancer Centre, KK Women's and Children's Hospital, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8944-7048","authenticated-orcid":true,"given":"Ruth Minothini","family":"Ashokan","sequence":"additional","affiliation":[{"name":"1Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore."},{"name":"2NUS Centre for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4199-2278","authenticated-orcid":true,"given":"Nurul Suhana Binte","family":"Ali Ahamed","sequence":"additional","affiliation":[{"name":"1Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore."},{"name":"2NUS Centre for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9886-9374","authenticated-orcid":true,"given":"CongBao","family":"Kang","sequence":"additional","affiliation":[{"name":"3Experimental Drug Development Centre, A*STAR, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2661-5954","authenticated-orcid":true,"given":"Chik Hong","family":"Kuick","sequence":"additional","affiliation":[{"name":"5Department of Pathology and Laboratory Medicine, KK Women's and Children's Hospital, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5244-4285","authenticated-orcid":true,"given":"Kenneth Tou En","family":"Chang","sequence":"additional","affiliation":[{"name":"4VIVA-KKH Paediatric Brain and Solid Tumour Programme, Children's Blood and Cancer Centre, KK Women's and Children's Hospital, Singapore."},{"name":"5Department of Pathology and Laboratory Medicine, KK Women's and Children's Hospital, Singapore."},{"name":"6Duke NUS Medical School, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6462-4387","authenticated-orcid":true,"given":"Sarit","family":"Larisch","sequence":"additional","affiliation":[{"name":"7Cell Death and Cancer Research Laboratory, Department of Human Biology and Medical Sciences, University of Haifa, Haifa, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8333-1486","authenticated-orcid":true,"given":"Amos Hong Pheng","family":"Loh","sequence":"additional","affiliation":[{"name":"4VIVA-KKH Paediatric Brain and Solid Tumour Programme, Children's Blood and Cancer Centre, KK Women's and Children's Hospital, Singapore."},{"name":"6Duke NUS Medical School, Singapore."},{"name":"7Cell Death and Cancer Research Laboratory, Department of Human Biology and Medical Sciences, University of Haifa, Haifa, Israel."},{"name":"8Department of Paediatric Surgery, KK Women's and Children's Hospital, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7796-2115","authenticated-orcid":true,"given":"Zhi Xiong","family":"Chen","sequence":"additional","affiliation":[{"name":"1Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore."},{"name":"2NUS Centre for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore."},{"name":"4VIVA-KKH Paediatric Brain and Solid Tumour Programme, Children's Blood and Cancer Centre, KK Women's and Children's Hospital, Singapore."},{"name":"9National University Cancer Institute, Singapore, National University Health System, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2023,11,22]]},"reference":[{"key":"2023112715334651300_bib1","doi-asserted-by":"crossref","first-page":"7394268","DOI":"10.1155\/2018\/7394268","article-title":"Neuroblastoma origin and therapeutic targets for immunotherapy","volume":"2018","author":"Kholodenko","year":"2018","journal-title":"J Immunol Res"},{"key":"2023112715334651300_bib2","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/MOP.0b013e32832b1240","article-title":"Recent advances in neuroblastoma","volume":"21","author":"Bowen","year":"2009","journal-title":"Curr Opin Pediatr"},{"key":"2023112715334651300_bib3","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(07)60983-0","article-title":"Neuroblastoma","volume":"369","author":"Maris","year":"2007","journal-title":"Lancet"},{"key":"2023112715334651300_bib4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.ne.14.030191.002321","article-title":"Cell death during development of the nervous system","volume":"14","author":"Oppenheim","year":"1991","journal-title":"Annu Rev Neurosci"},{"key":"2023112715334651300_bib5","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1083\/jcb.106.3.829","article-title":"Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation","volume":"106","author":"Martin","year":"1988","journal-title":"J Cell Biol"},{"key":"2023112715334651300_bib6","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1158\/1541-7786.MCR-13-0673","article-title":"Dynamic interactions between cancer cells and the embryonic microenvironment regulate cell invasion and reveal EphB6 as a metastasis suppressor","volume":"12","author":"Bailey","year":"2014","journal-title":"Mol Cancer Res"},{"key":"2023112715334651300_bib7","first-page":"1089","article-title":"Insitu neuroblastomas: a contribution to the natural history of neural crest tumors","volume":"43","author":"Beckwith","year":"1963","journal-title":"Am J Pathol"},{"key":"2023112715334651300_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12861-016-0132-y","article-title":"The E3 ubiquitin ligase Hace1 is required for early embryonic development in Xenopus laevis","volume":"16","author":"Iimura","year":"2016","journal-title":"BMC Dev Biol"},{"key":"2023112715334651300_bib9","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature14978","article-title":"Cell-fate determination by ubiquitin-dependent regulation of translation","volume":"525","author":"Werner","year":"2015","journal-title":"Nature"},{"key":"2023112715334651300_bib10","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1083\/jcb.200307130","article-title":"Critical function of endogenous XIAP in regulating caspase activation during sympathetic neuronal apoptosis","volume":"163","author":"Potts","year":"2003","journal-title":"J Cell Biol"},{"key":"2023112715334651300_bib11","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/35080103","article-title":"XIAP, the guardian angel","volume":"2","author":"Holcik","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2023112715334651300_bib12","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1600-0560.2007.00798.x","article-title":"Immunohistochemical detection of XIAP in melanoma","volume":"35","author":"Emanuel","year":"2008","journal-title":"J Cutan Pathol"},{"key":"2023112715334651300_bib13","doi-asserted-by":"crossref","first-page":"8369","DOI":"10.18632\/oncotarget.14207","article-title":"Preclinical assesement of survivin and XIAP as prognostic biomarkers and therapeutic targets in gastroenteropancreatic neuroendocrine neoplasia","volume":"8","author":"Dizdar","year":"2017","journal-title":"Oncotarget"},{"key":"2023112715334651300_bib14","doi-asserted-by":"crossref","first-page":"34229","DOI":"10.18632\/oncotarget.8748","article-title":"XAF1 promotes neuroblastoma tumor suppression and is required for KIF1Bbeta-mediated apoptosis","volume":"7","author":"Choo","year":"2016","journal-title":"Oncotarget"},{"key":"2023112715334651300_bib15","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1038\/sj.onc.1207523","article-title":"Toxic proteins released from mitochondria in cell death","volume":"23","author":"Saelens","year":"2004","journal-title":"Oncogene"},{"key":"2023112715334651300_bib16","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1074\/jbc.M109721200","article-title":"Identification of Omi\/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction","volume":"277","author":"Hegde","year":"2002","journal-title":"J Biol Chem"},{"key":"2023112715334651300_bib17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/35055027","article-title":"Identification of XAF1 as an antagonist of XIAP anti-Caspase activity","volume":"3","author":"Liston","year":"2001","journal-title":"Nat Cell Biol"},{"key":"2023112715334651300_bib18","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/35046566","article-title":"A novel mitochondrial septin-like protein, ARTS, mediates apoptosis dependent on its P-loop motif","volume":"2","author":"Larisch","year":"2000","journal-title":"Nat Cell Biol"},{"key":"2023112715334651300_bib19","first-page":"S14","article-title":"Inhibitor of apoptosis proteins: promising targets for cancer therapy","volume":"Suppl 14","author":"Owens","year":"2013","journal-title":"J Carcinog Mutagen"},{"key":"2023112715334651300_bib20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bbrc.2008.10.139","article-title":"Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2","volume":"378","author":"Cossu","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"2023112715334651300_bib21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s41419-020-2670-2","article-title":"A small-molecule ARTS mimetic promotes apoptosis through degradation of both XIAP and Bcl-2","volume":"11","author":"Mamriev","year":"2020","journal-title":"Cell Death Dis"},{"key":"2023112715334651300_bib22","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1111\/cas.14610","article-title":"Neuroblastoma patient-derived cultures are enriched for a mesenchymal gene signature and reflect individual drug response","volume":"111","author":"Hee","year":"2020","journal-title":"Cancer Sci"},{"key":"2023112715334651300_bib23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF00197809","article-title":"NMRPipe: a multidimensional spectral processing system based on UNIX pipes","volume":"6","author":"Delaglio","year":"1995","journal-title":"J Biomol NMR"},{"key":"2023112715334651300_bib24","first-page":"313","article-title":"Using NMRView to visualize and analyze the NMR spectra of macromolecules","volume":"278","author":"Johnson","year":"2004","journal-title":"Methods Mol Biol"},{"key":"2023112715334651300_bib25","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"},{"key":"2023112715334651300_bib26","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/jjco\/hyx176","article-title":"Neuroblastoma","volume":"48","author":"Nakagawara","year":"2018","journal-title":"Jpn J Clin Oncol"},{"key":"2023112715334651300_bib27","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1158\/1078-0432.CCR-16-0308","article-title":"A phase I dose-escalation study evaluating the safety tolerability and pharmacokinetics of CUDC-427, a potent, oral, monovalent IAP antagonist, in patients with refractory solid tumors","volume":"22","author":"Tolcher","year":"2016","journal-title":"Clin Cancer Res"},{"key":"2023112715334651300_bib28","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1200\/JCO.2013.52.3993","article-title":"Phase I dose-escalation study of LCL161, an oral inhibitor of apoptosis proteins inhibitor, in patients with advanced solid tumors","volume":"32","author":"Infante","year":"2014","journal-title":"J Clin Oncol"},{"key":"2023112715334651300_bib29","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1021\/jm101505d","article-title":"A potent and orally active antagonist (SM-406\/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment","volume":"54","author":"Cai","year":"2011","journal-title":"J Med Chem"},{"key":"2023112715334651300_bib30","doi-asserted-by":"crossref","first-page":"30718","DOI":"10.1074\/jbc.M705258200","article-title":"A dimeric Smac\/DIABLO peptide directly relieves caspase-3 inhibition by XIAP. Dynamic and cooperative regulation of XIAP by Smac\/DIABLO","volume":"282","author":"Gao","year":"2007","journal-title":"J Biol Chem"},{"key":"2023112715334651300_bib31","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/sj.cdd.4402024","article-title":"Apoptosome dependent caspase-3 activation pathway is non-redundant and necessary for apoptosis in sympathetic neurons","volume":"14","author":"Wright","year":"2007","journal-title":"Cell Death Differ"},{"key":"2023112715334651300_bib32","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3346\/jkms.2009.24.4.605","article-title":"Overexpression of X-linked inhibitor of apoptosis protein (XIAP) is an independent unfavorable prognostic factor in childhood de novo acute myeloid leukemia","volume":"24","author":"Sung","year":"2009","journal-title":"J Korean Med Sci"},{"key":"2023112715334651300_bib33","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1158\/1078-0432.CCR-03-0642","article-title":"High expression levels of X-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia","volume":"10","author":"Tamm","year":"2004","journal-title":"Clin Cancer Res"},{"key":"2023112715334651300_bib34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.chembiol.2017.09.009","article-title":"The advantages of targeted protein degradation over inhibition: an RTK case study","volume":"25","author":"Burslem","year":"2018","journal-title":"Cell Chem Biol"},{"key":"2023112715334651300_bib35","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/cdd.2009.81","article-title":"XIAP as a ubiquitin ligase in cellular signaling","volume":"17","author":"Galban","year":"2010","journal-title":"Cell Death Differ"},{"key":"2023112715334651300_bib36","doi-asserted-by":"crossref","first-page":"36611","DOI":"10.1074\/jbc.M200317200","article-title":"Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro","volume":"277","author":"MacFarlane","year":"2002","journal-title":"J Biol Chem"},{"key":"2023112715334651300_bib37","doi-asserted-by":"crossref","first-page":"113247","DOI":"10.1016\/j.ejmech.2021.113247","article-title":"Specific non-genetic IAP-based protein erasers (SNIPERs) as a potential therapeutic strategy","volume":"216","author":"Ma","year":"2021","journal-title":"Eur J Med Chem"},{"key":"2023112715334651300_bib38","doi-asserted-by":"crossref","first-page":"7169","DOI":"10.1021\/jm8006849","article-title":"Structure-based design, synthesis, evaluation, and crystallographic studies of conformationally constrained Smac mimetics as inhibitors of the X-linked inhibitor of apoptosis protein (XIAP)","volume":"51","author":"Sun","year":"2008","journal-title":"J Med Chem"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-23-0082\/3376089\/crc-23-0082.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/3\/11\/2386\/3387244\/crc-23-0082.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/3\/11\/2386\/3387244\/crc-23-0082.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T10:35:08Z","timestamp":1701081308000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/3\/11\/2386\/730232\/Targeted-Degradation-of-XIAP-is-Sufficient-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,22]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11,22]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-23-0082","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.24625618.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625630.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625606","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625621.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625627.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625618","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625624","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625612","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625648","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625624.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625636","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625612.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625633","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625621","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625651","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625606.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625609.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625615.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625648.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625600.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625609","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625651.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625654.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625645.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625639","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625627","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625603.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625645","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625615","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625603","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625636.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625642","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625630","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625642.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625600","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625654","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625633.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.24625639.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.6944819","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6944819.v1","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,22]]}}}